These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9098957)

  • 1. Synthesis of 2"-oxidized derivatives of 5-deoxy-5-epi-5-fluoro-dibekacin and -arbekacin, and study on structure-chemical shift relationships of urethane(or amide)-type NH protons in synthetic intermediates.
    Kobayashi Y; Tsuchiya T
    Carbohydr Res; 1997 Mar; 298(4):261-77. PubMed ID: 9098957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of varying the 4''-position of arbekacin derivatives on antibacterial activity against MRSA and Pseudomonas aeruginosa.
    Hiraiwa Y; Minowa N; Usui T; Akiyama Y; Maebashi K; Ikeda D
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6369-72. PubMed ID: 17889537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and antibacterial activity of 5-deoxy-5-episubstituted arbekacin derivatives.
    Hiraiwa Y; Usui T; Akiyama Y; Maebashi K; Minowa N; Ikeda D
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3540-3. PubMed ID: 17502146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of 5-deoxy-5-epifluoro derivatives of arbekacin, amikacin, and 1-N-[(S)-4-amino-2-hydroxybutanoyl]tobramycin (study on structure--toxicity relationships).
    Shitara T; Umemura E; Tsuchiya T; Matsuno T
    Carbohydr Res; 1995 Oct; 276(1):75-89. PubMed ID: 8536259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of low-toxicity, 5-deoxy-5-fluoro and 5-deoxy-5,5-difluoro derivatives of arbekacin and its analogs, and study of structure-toxicity relationships.
    Tsuchiya T; Shitara T; Umezawa S; Takeuchi T; Hamada M; Tomono N; Umemura E
    Carbohydr Res; 1993 Feb; 240():307-12. PubMed ID: 8458012
    [No Abstract]   [Full Text] [Related]  

  • 6. Synthesis of 2''-amino-2''-deoxyarbekacin and its analogs having potent activity against methicillin-resistant Staphylococcus aureus.
    Kondo S; Ikeda Y; Ikeda D; Takeuchi T; Usui T; Ishii M; Kudo T; Gomi S; Shibahara S
    J Antibiot (Tokyo); 1994 Jul; 47(7):821-32. PubMed ID: 8071128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 1-N-[(2S,4S)- and (2S,4R)-5-amino-4-fluoro-2-hydroxypentanoyl]dibekacins (study on structure-toxicity relationships).
    Takahashi Y; Kohno J; Tsuchiya T
    Carbohydr Res; 1998 Jan; 306(3):349-60. PubMed ID: 9648245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antibacterial activity of 4″ or 6″-alkanoylamino derivatives of arbekacin.
    Sasaki K; Kobayashi Y; Kurihara T; Yamashita Y; Takahashi Y; Miyake T; Akamatsu Y
    J Antibiot (Tokyo); 2015 Dec; 68(12):741-7. PubMed ID: 25990952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of dibekacin analogs containing 3-oxa- and 3-aza-2,3,4-trideoxy-D-glycero-hexopyranose.
    Kuwahara R; Tsuchiya T
    Carbohydr Res; 1996 Oct; 293(1):15-20. PubMed ID: 8916543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The novel enzymatic 3''-N-acetylation of arbekacin by an aminoglycoside 3-N-acetyltransferase of Streptomyces origin and the resulting activity.
    Hotta K; Sunada A; Ishikawa J; Mizuno S; Ikeda Y; Kondo S
    J Antibiot (Tokyo); 1998 Aug; 51(8):735-42. PubMed ID: 9766465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A newly recognized acetylated metabolite of arbekacin in arbekacin-resistant strains of methicillin-resistant Staphylococcus aureus.
    Fujimura S; Tokue Y; Takahashi H; Nukiwa T; Hisamichi K; Mikami T; Watanabe A
    J Antimicrob Chemother; 1998 Apr; 41(4):495-7. PubMed ID: 9598784
    [No Abstract]   [Full Text] [Related]  

  • 12. Aranorosin circumvents arbekacin-resistance in MRSA by inhibiting the bifunctional enzyme AAC(6')/APH(2″).
    Suga T; Ishii T; Iwatsuki M; Yamamoto T; Nonaka K; Masuma R; Matsui H; Hanaki H; Omura S; Shiomi K
    J Antibiot (Tokyo); 2012 Oct; 65(10):527-9. PubMed ID: 22760297
    [No Abstract]   [Full Text] [Related]  

  • 13. New 2''-amino derivatives of arbekacin, potent aminoglycoside antibiotics against methicillin-resistant Staphylococcus aureus.
    Kondo S; Shibahara S; Usui T; Kudo T; Tamura A; Gomi S; Ikeda Y; Ikeda D; Takeuchi T
    J Antibiot (Tokyo); 1993 Mar; 46(3):531-4. PubMed ID: 8478274
    [No Abstract]   [Full Text] [Related]  

  • 14. [Development of arbekacin and synthesis of new derivatives stable to enzymatic modifications by methicillin-resistant Staphylococcus aureus].
    Kondo S
    Jpn J Antibiot; 1994 Jun; 47(6):561-74. PubMed ID: 8072163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of the semi-synthetic kanamycin B derivative, arbekacin against methicillin-resistant Staphylococcus aureus.
    Hamilton-Miller JM; Shah S
    J Antimicrob Chemother; 1995 Jun; 35(6):865-8. PubMed ID: 7559197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antibacterial activity of 1-N-[(S)-ω-amino-2-hydroxyalkyl] derivatives of dibekacin, 5-deoxydibekacin, 3'-deoxykanamycin A and gentamicin B.
    Umemura E; Sakamoto Y; Takahashi Y; Miyake T
    J Antibiot (Tokyo); 2015 Jun; 68(6):421-3. PubMed ID: 25712399
    [No Abstract]   [Full Text] [Related]  

  • 17. Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus.
    Kondo S; Tamura A; Gomi S; Ikeda Y; Takeuchi T; Mitsuhashi S
    J Antibiot (Tokyo); 1993 Feb; 46(2):310-5. PubMed ID: 8468247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of arbekacin against clinical isolates of methicillin-resistant Staphylococcus aureus in a hospital.
    Kawakami Y; Furuwatari C; Akahane T; Okimura Y; Furihata K; Katsuyama T; Matsumoto H
    J Antibiot (Tokyo); 1994 Apr; 47(4):507-9. PubMed ID: 8195054
    [No Abstract]   [Full Text] [Related]  

  • 19. An Isolated Method and Assignment for Critical Impurities in Semi-Synthetic Process of Arbekacin Sulfate.
    Chen ZH; Zhou H; Wang S; Li G; Zhang J; Wang F; Li C; Qiao RZ
    Pharmazie; 2019 Jun; 74(6):352-356. PubMed ID: 31138373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic 2'-N-acetylation of arbekacin and antibiotic activity of its product.
    Hotta K; Zhu CB; Ogata T; Sunada A; Ishikawa J; Mizuno S; Ikeda Y; Kondo S
    J Antibiot (Tokyo); 1996 May; 49(5):458-64. PubMed ID: 8682723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.